8HKH
Crystal structure of the LC/A1-DARPin18 complex
8HKH の概要
| エントリーDOI | 10.2210/pdb8hkh/pdb |
| 分子名称 | BoNT/A, Designed ankyrin repeat protein 18, ZINC ION, ... (4 entities in total) |
| 機能のキーワード | botulinum neurotoxin, darpin, catalytic domain, toxin |
| 由来する生物種 | Clostridium botulinum 詳細 |
| タンパク質・核酸の鎖数 | 4 |
| 化学式量合計 | 132718.27 |
| 構造登録者 | |
| 主引用文献 | Leka, O.,Wu, Y.,Zanetti, G.,Furler, S.,Reinberg, T.,Marinho, J.,Schaefer, J.V.,Pluckthun, A.,Li, X.,Pirazzini, M.,Kammerer, R.A. A DARPin promotes faster onset of botulinum neurotoxin A1 action. Nat Commun, 14:8317-8317, 2023 Cited by PubMed Abstract: In this study, we characterize Designed Ankyrin Repeat Proteins (DARPins) as investigative tools to probe botulinum neurotoxin A1 (BoNT/A1) structure and function. We identify DARPin-F5 that completely blocks SNAP25 substrate cleavage by BoNT/A1 in vitro. X-ray crystallography reveals that DARPin-F5 inhibits BoNT/A1 activity by interacting with a substrate-binding region between the α- and β-exosite. This DARPin does not block substrate cleavage of BoNT/A3, indicating that DARPin-F5 is a subtype-specific inhibitor. BoNT/A1 Glu-171 plays a critical role in the interaction with DARPin-F5 and its mutation to Asp, the residue found in BoNT/A3, results in a loss of inhibition of substrate cleavage. In contrast to the in vitro results, DARPin-F5 promotes faster substrate cleavage of BoNT/A1 in primary neurons and muscle tissue by increasing toxin translocation. Our findings could have important implications for the application of BoNT/A1 in therapeutic areas requiring faster onset of toxin action combined with long persistence. PubMed: 38110403DOI: 10.1038/s41467-023-44102-4 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.7 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






